ZNTL icon

Zentalis Pharmaceuticals
ZNTL

Overview Fund Activity

142 hedge funds and large institutions have $1.34B invested in Zentalis Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 14 closing their positions.

Holders
142
Holders Change
+22
Holders Change %
+18.33%
% of All Funds
2.06%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
36
Increased
43
Reduced
38
Closed
14
Calls
$1.14M
Puts
$36K
Net Calls
+$1.11M
Net Calls Change
-$15.4M

Top Buyers

1
MB
1
MPM BioImpact
Massachusetts
$23.9M
2
T. Rowe Price Investment Management
2
T. Rowe Price Investment Management
Maryland
$52.3M
3
Verition Fund Management
3
Verition Fund Management
Connecticut
$18.2M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$55M
5
PBA
5
Paradigm Biocapital Advisors
New York
$14.9M

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$69.3M
2
State Street
2
State Street
Massachusetts
$59.7M
3
Bank of America
3
Bank of America
North Carolina
$7.5M
4
IHAM
4
Integral Health Asset Management
New York
$0
5
Ensign Peak Advisors
5
Ensign Peak Advisors
Utah
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MCMC
1
Matrix Capital Management Company
New Hampshire
$220M 13,959,973 – –
EAM
2
Eventide Asset Management
Massachusetts
$182M 11,574,821 +14,846 +0.1%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$168M 10,644,024 +307,053 +3%
BlackRock
4
BlackRock
New York
$73.2M 4,645,758 -39,217 -0.8%
Vanguard Group
5
Vanguard Group
Pennsylvania
$69.3M 4,398,625 -951,833 -18%
Citadel Advisors
6
Citadel Advisors
Florida
$60.7M 3,852,429 +170,647 +5%
State Street
7
State Street
Massachusetts
$59.7M 3,785,652 -631,404 -14%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$55M 3,489,709 +585,644 +20%
T. Rowe Price Investment Management
9
T. Rowe Price Investment Management
Maryland
$52.3M 3,319,086 +977,303 +42%
Capital International Investors
10
Capital International Investors
California
$44.4M 2,819,664 – –
DC
11
Decheng Capital
California
$33.1M 2,099,583 – –
Federated Hermes
12
Federated Hermes
Pennsylvania
$31.5M 1,998,700 -161,865 -7%
MB
13
MPM BioImpact
Massachusetts
$23.9M 1,516,183 +1,516,183 New
WP
14
Woodline Partners
California
$22.6M 1,437,026 +33,473 +2%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$20.5M 1,302,237 +48,500 +4%
Primecap Management
16
Primecap Management
California
$18.4M 1,164,610 +141,260 +14%
Verition Fund Management
17
Verition Fund Management
Connecticut
$18.2M 1,155,236 +810,619 +235%
Morgan Stanley
18
Morgan Stanley
New York
$16.3M 1,037,409 -181,557 -15%
TCM
19
Tybourne Capital Management
Hong Kong
$15.2M 961,486 – –
PBA
20
Paradigm Biocapital Advisors
New York
$14.9M 944,917 +544,917 +136%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$11.4M 723,656 -377 -0.1%
Northern Trust
22
Northern Trust
Illinois
$8.25M 523,702 -6,301 -1%
5VM
23
5AM Venture Management
California
$7.72M 490,000 – –
Bank of America
24
Bank of America
North Carolina
$7.5M 475,956 -242,687 -34%
Charles Schwab
25
Charles Schwab
California
$7.19M 455,937 +10,114 +2%
1
2 3 4 5